BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32845895)

  • 1. Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.
    An J; Kim HI; Chang S; Shim JH
    PLoS One; 2020; 15(8):e0238078. PubMed ID: 32845895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
    Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
    Moon AM; Weiss NS; Beste LA; Su F; Ho SB; Jin GY; Lowy E; Berry K; Ioannou GN
    Gastroenterology; 2018 Oct; 155(4):1128-1139.e6. PubMed ID: 29981779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
    Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
    PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.
    Zhang N; Gu J; Yin L; Wu J; Du MY; Ding K; Huang T; He X
    Oncotarget; 2016 Dec; 7(49):81389-81401. PubMed ID: 27835609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
    Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
    Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.
    Daniele B; Bencivenga A; Megna AS; Tinessa V
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S108-12. PubMed ID: 15508073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival.
    Trevisani F; Cantarini MC; Labate AM; De Notariis S; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
    Am J Gastroenterol; 2004 Aug; 99(8):1470-6. PubMed ID: 15307862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
    Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
    J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time.
    Lee E; Edward S; Singal AG; Lavieri MS; Volk M
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):437-40. PubMed ID: 23247324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.